Lista de obras -

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

artículo científico publicado en 2015

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort

artículo científico publicado en 2015

Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.

artículo científico publicado en 2005

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

artículo científico publicado en 2008

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma

scientific article published on 05 May 2009

Chromosomal instability in Barrett's esophagus is related to telomere shortening.

artículo científico publicado en 2006

Correction to: NSAID use and somatic exomic mutations in Barrett's esophagus

scholarly article published in Genome Medicine

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

artículo científico publicado en 2006

Deletion at fragile sites is a common and early event in Barrett's esophagus.

artículo científico publicado en 2010

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study

artículo científico publicado en 2008

Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

scientific article published on 01 October 2020

Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels.

artículo científico publicado en 2018

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

artículo científico publicado en 2007

Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays

artículo científico publicado en 2013

Flow cytometric enrichment for respiratory epithelial cells in sputum.

artículo científico publicado en 2004

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

artículo científico publicado en 2006

Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation

scientific article published on 01 March 2006

High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.

artículo científico publicado en 2015

Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH

scientific article published on 01 June 2007

Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

artículo científico publicado en 2005

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus

scientific article published on 20 July 2006

Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis

artículo científico publicado en 2006

NSAID use and somatic exomic mutations in Barrett's esophagus.

artículo científico publicado en 2018

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

artículo científico publicado en 2007

NSAIDs modulate clonal evolution in Barrett's esophagus.

artículo científico publicado en 2013

Neosquamous epithelium does not typically arise from Barrett's epithelium.

artículo científico publicado en 2006

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

artículo científico publicado en 2005

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study

artículo científico publicado en 2009

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

artículo científico publicado en 2002

Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues

artículo científico publicado en 2006

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus

artículo científico publicado en 2004

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

artículo científico publicado en 2003

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression

artículo científico publicado en 2008

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus

artículo científico publicado en 2013

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma

artículo científico publicado en 2004

Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria

artículo científico publicado en 2013

p16 mutation spectrum in the premalignant condition Barrett's esophagus

artículo científico publicado en 2008

Lista de obras de

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort

Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma

Chromosomal instability in Barrett's esophagus is related to telomere shortening.

Correction to: NSAID use and somatic exomic mutations in Barrett's esophagus

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

Deletion at fragile sites is a common and early event in Barrett's esophagus.

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study

Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels.

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays

Flow cytometric enrichment for respiratory epithelial cells in sputum.

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation

High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.

Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH

Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus

Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis

NSAID use and somatic exomic mutations in Barrett's esophagus.

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

NSAIDs modulate clonal evolution in Barrett's esophagus.

Neosquamous epithelium does not typically arise from Barrett's epithelium.

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma

Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria

p16 mutation spectrum in the premalignant condition Barrett's esophagus